Five leading cancer surgery centres across Europe will treat 500 patients. The validation studies will ensure that the CLASSICA technology and methods can be generalised across clinics and will help to optimise the AI assistance given to surgeons.
CLASSICA brings together experts in colorectal cancer, precision surgery, AI and technology, biomedical law and ethics, surgical training, and surgical guidelines.
CLASSICA builds on breakthrough research in the AI analysis of fluorescence and perfusion in cancer tissues. The technology will differentiate between cancerous and non-cancerous tissues in real-time.